PLx Pharma  logo

PLx Pharma PLXP

$ 0.09 -27.8%

Quarterly report 2022-Q3
added 11-10-2022

report update icon

Country

usaUSA

IPO year

2014

Industry

Drug manufacturers

Stock Exchange

NASDAQ CAPITAL

CEO

Mr. David Luci

Employees in the company

10

Shares

23.7 M

Market Cap[1]

$ 2.56 M

EBITDA (LTM)

$ -53.2 M

P/E (LTM)

-0.09

P/S (LTM)

0.54

EPS (LTM)

-1.92

Other stocks of industry "Drug manufacturers"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.